73.31
price down icon0.83%   -0.61
pre-market  プレマーケット:  71.00   -2.31   -3.15%
loading
前日終値:
$73.92
開ける:
$73.19
24時間の取引高:
219.70K
Relative Volume:
0.50
時価総額:
$1.64B
収益:
$883.37M
当期純損益:
$71.37M
株価収益率:
21.87
EPS:
3.3516
ネットキャッシュフロー:
$150.90M
1週間 パフォーマンス:
-1.31%
1か月 パフォーマンス:
-4.42%
6か月 パフォーマンス:
-22.82%
1年 パフォーマンス:
+11.11%
1日の値動き範囲:
Value
$72.82
$74.43
1週間の範囲:
Value
$72.20
$76.00
52週間の値動き範囲:
Value
$56.71
$99.50

Ani Pharmaceuticals Inc Stock (ANIP) Company Profile

Name
名前
Ani Pharmaceuticals Inc
Name
セクター
Healthcare (1113)
Name
電話
(218) 634-3500
Name
住所
210 MAIN STREET WEST, BAUDETTE, MN
Name
職員
970
Name
Twitter
Name
次回の収益日
2026-02-27
Name
最新のSEC提出書
Name
ANIP's Discussions on Twitter

Compare ANIP vs TAK, ZTS, HLN, TEVA, UTHR

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
ANIP icon
ANIP
Ani Pharmaceuticals Inc
73.31 1.64B 883.37M 71.37M 150.90M 3.3516
TAK icon
TAK
Takeda Pharmaceutical Co Adr
18.04 56.99B 29.85B 776.90M 4.35B 0.2408
ZTS icon
ZTS
Zoetis Inc
115.93 48.94B 9.47B 2.67B 2.28B 6.0218
HLN icon
HLN
Haleon Plc Adr
9.70 43.30B 14.54B 2.22B 2.58B 0.4871
TEVA icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
29.14 33.94B 17.41B 1.43B 1.00B 1.2182
UTHR icon
UTHR
United Therapeutics Corp
531.82 23.31B 3.18B 1.33B 1.04B 27.90

Ani Pharmaceuticals Inc Stock (ANIP) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-07-10 開始されました H.C. Wainwright Buy
2025-03-14 開始されました Jefferies Buy
2025-03-12 開始されました JP Morgan Overweight
2024-12-11 開始されました Leerink Partners Outperform
2024-10-11 開始されました Piper Sandler Overweight
2024-03-15 開始されました CapitalOne Overweight
2023-08-22 繰り返されました H.C. Wainwright Buy
2023-03-01 開始されました Guggenheim Buy
2022-09-07 開始されました H.C. Wainwright Buy
2021-11-02 開始されました Truist Buy
2020-05-07 ダウングレード Cantor Fitzgerald Overweight → Neutral
2019-09-12 開始されました Guggenheim Buy
2019-05-10 ダウングレード Raymond James Strong Buy → Outperform
2017-10-16 繰り返されました Canaccord Genuity Buy
2017-07-31 開始されました Canaccord Genuity Buy
2017-02-22 ダウングレード ROTH Capital Buy → Neutral
2016-06-23 開始されました Raymond James Strong Buy
2016-05-24 ダウングレード Standpoint Research Buy → Hold
2015-11-13 開始されました Standpoint Research Buy
2015-09-28 アップグレード ROTH Capital Neutral → Buy
2015-08-05 繰り返されました Oppenheimer Outperform
2015-08-04 繰り返されました ROTH Capital Neutral
2015-07-31 繰り返されました Oppenheimer Outperform
2015-07-15 繰り返されました ROTH Capital Neutral
2015-06-23 繰り返されました Oppenheimer Outperform
2015-05-18 繰り返されました ROTH Capital Neutral
2015-05-06 繰り返されました Oppenheimer Outperform
2015-04-10 ダウングレード ROTH Capital Buy → Neutral
2015-02-26 繰り返されました ROTH Capital Buy
2015-02-18 繰り返されました Oppenheimer Outperform
すべてを表示

Ani Pharmaceuticals Inc (ANIP) 最新ニュース

pulisher
Mar 24, 2026

INSM Stock Gains After Arikayce Hits Goal in Label Expansion Study - TradingView

Mar 24, 2026
pulisher
Mar 22, 2026

Oliver Luxxe Assets LLC Invests $1.82 Million in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat

Mar 22, 2026
pulisher
Mar 22, 2026

BioSante Pharmaceuticals and ANI Pharmaceuticals Announce Completion of Merger - Yahoo

Mar 22, 2026
pulisher
Mar 22, 2026

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Mar 22, 2026
pulisher
Mar 21, 2026

ANI Pharmaceuticals Expands Ophthalmology Reach As Valuation Signals Upside Potential - Yahoo Finance

Mar 21, 2026
pulisher
Mar 21, 2026

Assessing ANI Pharmaceuticals (ANIP) Valuation After Rare Disease Momentum And Alimera Acquisition - Sahm

Mar 21, 2026
pulisher
Mar 18, 2026

Puma Biotechnology Stock Declines More Than 9% in a Month: Here's Why - TradingView

Mar 18, 2026
pulisher
Mar 18, 2026

Agios Pharmaceuticals Stock Declines 23% in 6 Months: Here's Why - TradingView

Mar 18, 2026
pulisher
Mar 18, 2026

Guggenheim Remains a Buy on ANI Pharmaceuticals (ANIP) - The Globe and Mail

Mar 18, 2026
pulisher
Mar 18, 2026

ANIP Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Mar 18, 2026
pulisher
Mar 17, 2026

Is ANI Pharmaceuticals (ANIP) Pullback Hiding A Contradiction In Its Valuation Story - simplywall.st

Mar 17, 2026
pulisher
Mar 17, 2026

EPS Watch: Can ANI Pharmaceuticals Inc lead its sector in growthQuarterly Earnings Summary & Fast Entry Momentum Alerts - baoquankhu1.vn

Mar 17, 2026
pulisher
Mar 17, 2026

COGT Rise as FDA Accepts Bezuclastinib NDA in Non-Advanced SM - TradingView

Mar 17, 2026
pulisher
Mar 17, 2026

ANIP PE Ratio & Valuation, Is ANIP Overvalued - Intellectia AI

Mar 17, 2026
pulisher
Mar 16, 2026

IBRX Stock Jumps on Progress in NK Cell Therapy Production - TradingView

Mar 16, 2026
pulisher
Mar 16, 2026

Zacks Industry Outlook Features Terns Pharmaceuticals, ADMA Biologics, ANI Pharmaceuticals, and Liquidia - Bitget

Mar 16, 2026
pulisher
Mar 16, 2026

Zacks Industry Outlook Highlights Terns Pharmaceuticals, ADMA Biologics, ANI Pharmaceuticals and Liquidia - The Globe and Mail

Mar 16, 2026
pulisher
Mar 16, 2026

ANI Pharmaceuticals Insiders Unload $584K in Shares Amid 18-Month Selling Streak - AlphaStreet

Mar 16, 2026
pulisher
Mar 16, 2026

234,219 Shares in ANI Pharmaceuticals, Inc. $ANIP Acquired by Divisadero Street Capital Management LP - MarketBeat

Mar 16, 2026
pulisher
Mar 15, 2026

Apis Capital Advisors LLC Purchases 36,000 Shares of ANI Pharmaceuticals, Inc. $ANIP - MarketBeat

Mar 15, 2026
pulisher
Mar 14, 2026

Form 4 ANI Pharmaceuticals Inc For: 13 March By Investing.com - Investing.com Australia

Mar 14, 2026
pulisher
Mar 14, 2026

ANI Pharmaceuticals (NASDAQ:ANIP) Stock Rating Lowered by Wall Street Zen - MarketBeat

Mar 14, 2026
pulisher
Mar 14, 2026

Ani Pharmaceuticals SVP Cook sells $36k in stock - Investing.com

Mar 14, 2026
pulisher
Mar 14, 2026

Ani Pharmaceuticals SVP Cook sells $36k in stock By Investing.com - Investing.com South Africa

Mar 14, 2026
pulisher
Mar 13, 2026

Meredith Cook Sells 500 Shares of ANI Pharmaceuticals (NASDAQ:ANIP) Stock - MarketBeat

Mar 13, 2026
pulisher
Mar 13, 2026

Insider Selling: ANI Pharmaceuticals (NASDAQ:ANIP) Insider Sells 3,162 Shares of Stock - MarketBeat

Mar 13, 2026
pulisher
Mar 13, 2026

ANI Pharmaceuticals (NASDAQ:ANIP) SVP Thomas Andrew Rowland Sells 4,772 Shares - MarketBeat

Mar 13, 2026
pulisher
Mar 13, 2026

Ani pharmaceuticals SVP Rowland sells $357k in stock By Investing.com - Investing.com South Africa

Mar 13, 2026
pulisher
Mar 13, 2026

Ani pharmaceuticals SVP Rowland sells $357k in stock - Investing.com

Mar 13, 2026
pulisher
Mar 13, 2026

[Form 4] ANI PHARMACEUTICALS INC Insider Trading Activity - Stock Titan

Mar 13, 2026
pulisher
Mar 13, 2026

ANI Pharmaceuticals (ANIP) legal chief sells 500 shares under 10b5-1 plan - Stock Titan

Mar 13, 2026
pulisher
Mar 13, 2026

Allogene Therapeutics Posts Narrower-Than-Expected Loss in Q4 - TradingView

Mar 13, 2026
pulisher
Mar 13, 2026

ANI Pharmaceuticals, Inc. $ANIP Stock Position Reduced by Kennedy Capital Management LLC - MarketBeat

Mar 13, 2026
pulisher
Mar 13, 2026

Sizing Up ANI Pharmaceuticals (ANIP) After Recent Share Price Pullback - Yahoo Finance

Mar 13, 2026
pulisher
Mar 12, 2026

Pharma Sector Q1 2026 Earnings Review: Mixed Results & Future OutlookNews and Statistics - IndexBox

Mar 12, 2026
pulisher
Mar 12, 2026

How ANI’s Reaffirmed 2026 Guidance and Rare Disease Push Will Impact ANI Pharmaceuticals (ANIP) Investors - simplywall.st

Mar 12, 2026
pulisher
Mar 12, 2026

Beam Therapeutics Stock Surges 23% in 6 Months: What's Driving It? - TradingView

Mar 12, 2026
pulisher
Mar 12, 2026

ANIP SEC FilingsAni Pharmaceutic 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 12, 2026
pulisher
Mar 12, 2026

ANI Pharmaceuticals touts rare-disease pivot at Barclays, guides 2026 revenue above $1B - MarketBeat

Mar 12, 2026
pulisher
Mar 11, 2026

ANI Pharmaceuticals at Barclays Conference: Rare Disease Focus Drives Growth - Investing.com Canada

Mar 11, 2026
pulisher
Mar 11, 2026

Mineralys Stock Rises as FDA Accepts NDA for Hypertension Drug - TradingView

Mar 11, 2026
pulisher
Mar 11, 2026

ANI Pharmaceuticals Targets $1.1B 2026 Revenue as Cortrophin Sales Surge, Gout Launch Set for Midyear - MarketBeat

Mar 11, 2026
pulisher
Mar 11, 2026

Insider Sell: Krista Davis Sells Shares of ANI Pharmaceuticals I - GuruFocus

Mar 11, 2026
pulisher
Mar 10, 2026

ANI Pharmaceuticals (NASDAQ: ANIP) executive sells shares, withholds stock for taxes - Stock Titan

Mar 10, 2026
pulisher
Mar 10, 2026

ANI Pharmaceuticals (ANIP) CEO stock withheld to cover taxes - Stock Titan

Mar 10, 2026
pulisher
Mar 10, 2026

ANI Pharmaceuticals (ANIP) HR chief sells 6,572 shares under 10b5-1 plan - Stock Titan

Mar 10, 2026
pulisher
Mar 10, 2026

GSK Out-Licenses Rights for Rare Liver Disease Drug to Alfasigma - Finviz

Mar 10, 2026
pulisher
Mar 10, 2026

BMY Advances CELMoD Program With Positive Phase III Results - TradingView

Mar 10, 2026
pulisher
Mar 10, 2026

ANIP Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

Mar 10, 2026
pulisher
Mar 09, 2026

Ani pharmaceuticals head of rare disease sells $30k in stock - Investing.com Nigeria

Mar 09, 2026
pulisher
Mar 09, 2026

INCY Wins EC Approval for Label Expansion of Oncology Drug Zynyz - Finviz

Mar 09, 2026

Ani Pharmaceuticals Inc (ANIP) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
RDY RDY
$13.45
price down icon 1.75%
RGC RGC
$24.43
price down icon 3.13%
$24.90
price up icon 1.88%
$127.86
price up icon 0.64%
$13.36
price up icon 0.53%
$531.82
price up icon 2.03%
大文字化:     |  ボリューム (24 時間):